Osteoporosis drug may treat breast and liver cancers

In 2007, the agency approved the use of raloxifene for reducing the risk of invasive breast cancer in post-menopausal women with osteoporosis and in post-menopausal women at high risk for invasive breast cancer, which spreads outside the lobules or …

http://ift.tt/eA8V8J